Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD7 Positive”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Early research (Phase 1)Looking for participantsNCT06732492
What this trial is testing

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Who this might be right for
NK T-Cell LymphomaCART TherapyCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Very early researchUnknownNCT05979792
What this trial is testing

Clinical Study of CD7 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory CD7-positive Peripheral T Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Zhao Weili 35
Early research (Phase 1)UnknownNCT04480788
What this trial is testing

CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study

Who this might be right for
T Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Very early researchStudy completedNCT05907603
What this trial is testing

Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Kai Lin Xu，MD 8
Very early researchNot Yet RecruitingNCT06849401
What this trial is testing

The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia

Who this might be right for
T-ALL
Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)Looking for participantsNCT07188610
What this trial is testing

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Who this might be right for
CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 100
Not applicableStudy completedNCT04938115
What this trial is testing

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Who this might be right for
Leukemia, T Cell
Hebei Senlang Biotechnology Inc., Ltd. 50
Early research (Phase 1)UnknownNCT05170568
What this trial is testing

PA3-17 Injection Treatment of Adult Patients With CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies

Who this might be right for
CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 22
Testing effectiveness (Phase 2)Looking for participantsNCT05827835
What this trial is testing

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Who this might be right for
Hematologic DiseasesNeoplasms
Zhejiang University 30
Early research (Phase 1)Not Yet RecruitingNCT05995028
What this trial is testing

Universal 4SCAR7U Targeting CD7-positive Malignancies

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic LymphomaAcute Myeloid Leukemia+1 more
Shenzhen Geno-Immune Medical Institute 30
Very early researchStudy completedNCT05902845
What this trial is testing

RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsHematologic Diseases
Xiaoyu Zhu 4
Very early researchStudy completedNCT05895994
What this trial is testing

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
MEI HENG 2
Very early researchLooking for participantsNCT07338604
What this trial is testing

Clinical Study of UTAA07 Injection in the Treatment of Hematologic and Lymphatic Systemic Malignancies

Who this might be right for
Hematolymphoid Malignancies
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 15
Not applicableUnknownNCT04785833
What this trial is testing

CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia

Who this might be right for
T-ALL
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT07280494
What this trial is testing

To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT

Who this might be right for
CD7+ T-ALL/LBL
Peking University People's Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT06720324
What this trial is testing

CD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors

Who this might be right for
Hematologic Malignancy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Early research (Phase 1)Study completedNCT04572308
What this trial is testing

Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

Who this might be right for
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 20
Very early researchStudy completedNCT05716113
What this trial is testing

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
NeoplasmsHematologic NeoplasmsNeoplasms by Site+1 more
He Huang 20
Testing effectiveness (Phase 2)Looking for participantsNCT07106723
What this trial is testing

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

Who this might be right for
CD7 PositiveT - Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 50
Next Page